Substance / Medication

Escitalopram

Overview

Active Ingredient
escitalopram
RxNorm CUI
321988

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

117 trials linked to this intervention

117
Total Trials
9
Recruiting
53
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Effects of the selective serotonin reuptake inhibitors citalopram and escitalopram on glucolipid metabolism: a systematic review.
Dai Yajing, Zhao Mingzhe, Li Mian et al. · Front Endocrinol (Lausanne) · 2025
PMID: 40600014Meta-AnalysisFull text (PMC)
Escitalopram and functional connectivity in major depressive disorder: A systematic review.
Turiaco Fabrizio, Arnone Federico, Drago Antonio et al. · J Psychopharmacol · 2025
PMID: 41025521Meta-Analysis
Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review.
Talaee Nastaran, Azadvar Shataw, Khodadadi Sanaz et al. · Eur J Clin Pharmacol · 2024
PMID: 38558317Meta-Analysis
Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis.
Yin Juntao, Song Xiaoyong, Wang Chaoyang et al. · BMC Psychiatry · 2023
PMID: 38001423Meta-AnalysisFull text (PMC)
Prediction of Ventricular Arrhythmias by QRS/QTc - Ratio in Citalopram or Escitalopram Intoxication.
Dietrichs Erik Sveberg, Smith Godfrey L · Front Med (Lausanne) · 2022
PMID: 35372426Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Escitalopram (substance)
SNOMED CT
400447003
UMLS CUI
C1099456
RxNorm CUI
321988

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
117
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.